BioPharma Credit (BPCR) Insider Trading & Ownership GBX 0.86 +0.00 (+0.47%) As of 05/2/2025 11:46 AM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsDividendInsider TradesBuy This Stock BioPharma Credit (LON:BPCR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.18%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)£77,571.74Number OfInsiders Selling(Last 3 Years)0 Get BPCR Insider Trade Alerts Want to know when executives and insiders are buying or selling BioPharma Credit stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BPCR Insider Buying and Selling by Quarter BioPharma Credit Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/27/2024Sapna ShahInsiderBuy20,000GBX 72£14,4003/27/2023Sapna ShahInsiderBuy22,342GBX 97£21,671.7410/24/2022Rolf SoderstromInsiderBuy50,000GBX 83£41,500 (Data available from 1/1/2013 forward) BPCR Insider Trading Activity - Frequently Asked Questions Who is on BioPharma Credit's Insider Roster? The list of insiders at BioPharma Credit includes Rolf Soderstrom, and Sapna Shah. Learn more on insiders at BPCR. What percentage of BioPharma Credit stock is owned by insiders? 6.18% of BioPharma Credit stock is owned by insiders. Learn more on BPCR's insider holdings. Which BioPharma Credit insiders have been buying company stock? The following insider purchased BPCR shares in the last 24 months: Sapna Shah (£14,400). How much insider buying is happening at BioPharma Credit? Insiders have purchased a total of 20,000 BPCR shares in the last 24 months for a total of £14,400 bought. BioPharma Credit Key ExecutivesMr. Pedro Gonzalez de CosioInvestment ManagerMr. Pablo Gerardo Legorreta (Age 59)Investment Manager Mr. Martin G. Friedman (Age 58)Investment Manager More Insider Trading Tools from MarketBeat Related Companies 3i Infrastructure Insider Trades Petershill Partners Insider Trades RIT Capital Partners Insider Trades abrdn Insider Trades JPMorgan Global Growth & Income Insider Trades HgCapital Trust Insider Trades Man Group Insider Trades HICL Infrastructure Insider Trades City of London Insider Trades HarbourVest Global Private Equity Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (LON:BPCR) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BPCR Stock Free BPCR Stock Alerts